Finance

Lists
FFEA:FRA
FAES Farma SA
€4.44
0.00%
(0.00) 1D
Aug 5, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FFEA...
Open
€4.44
High
€4.44
Low
€4.44
Mkt. cap
1.42B
Avg. vol.
3.00
Volume
0.00
Dividend
2.88%
Quarterly dividend
€0.03
Ex-dividend date
Jul 2, 2026
P/E ratio
16.51
52-wk high
€5.49
52-wk low
€4.10
EPS
€0.27
No. of employees
3K
Open
€4.44
High
€4.44
Low
€4.44
Mkt. cap
1.42B
Avg. vol.
3.00
Volume
0.00
Dividend
2.88%
Quarterly dividend
€0.03
Ex-dividend date
Jul 2, 2026
P/E ratio
16.51
52-wk high
€5.49
52-wk low
€4.10
EPS
€0.27
No. of employees
3K
News stories
From sources across the web
Profile
Faes Farma, originally Fábrica Española de Productos Químicos y Farmacéuticos, is a Spanish pharmaceutical company based in the Lamiaco district of Lejona in Biscay. Founded on 29 July 1933 by the Serra family with an initial capital of two million pesetas, it pioneered the development of various therapeutic compounds and has been listed on the Madrid Stock Exchange since the 1940s. Faes Farma’s headquarters, production facilities, and R&D center are located in Lejona, with additional offices in Madrid and Barcelona. The group also operates subsidiaries in Portugal, Italy, Mexico, Guatemala, Colombia, Chile, Peru, Bolivia, Ecuador and Nigeria, and maintains an animal nutrition and health division under the name FARM Faes. Wikipedia
About FAES Farma SA
CEO-
Employees2.61K
FoundedJul 29, 1933
Headquarters-
SectorPharmaceutical industry
Websitefaesfarma.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
146.61M
172.99M
200.07M
191.39M
Cost of goods sold
52.40M
73.44M
61.59M
60.25M
Cost of revenue
52.40M
73.44M
61.59M
60.25M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.36M
80.84M
45.67M
44.06M
Operating expense
68.06M
98.44M
100.13M
98.54M
Total operating expenses
120.47M
171.88M
161.72M
158.78M
Operating income
26.14M
1.11M
38.35M
32.61M
Other non operating income
401.00K
1.02M
-
1.41M
EBT including unusual items
25.18M
-1.39M
36.36M
30.47M
EBT excluding unusual items
25.18M
-1.65M
36.36M
30.47M
Income tax expense
3.75M
-7.43M
5.49M
4.32M
Effective tax rate
14.91%
534.46%
15.10%
14.19%
Other operating expenses
33.65M
7.21M
44.62M
44.44M
Net income
21.23M
6.07M
30.79M
26.10M
Net profit margin
14.48%
3.51%
15.39%
13.64%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.99M
-3.51M
-1.99M
-3.58M
Net interest expenses
-1.99M
-3.51M
-1.99M
-3.58M
Depreciation and amortization charges
7.05M
10.39M
9.83M
10.04M
EBITDA
30.15M
6.94M
44.19M
38.44M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps